check_circleStudy Completed

Magnetic Resonance Imaging

Bayer Identifier:
Trial_90104
ClinicalTrials.gov Identifier:
Not Available
EudraCT Number:
Not Available
EU CT Number:
Not Available
Magnevist in newborns and infants up to the second year of life in CNS indications

Trial purpose

Please see attached Study Results Summary below

Key Participants Requirements

Sex

N/A

Age

9 - 23 Months

Trial summary

Enrollment Goal
72
Trial Dates
March 1991 - May 1992
Phase
Phase 3
Could I Receive a placebo
N/A
Products
Magnevist (Gadopentetate Dimeglumine, BAY86-4882)
Accepts Healthy Volunteer
N/A

Trial design

An open, multicenter clinical trial of Magnevist® in newborns and infants up to the second year of life in CNS indications
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A

Additional Information

Click here and search for drug information provided by the FDA.Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.Click here to find results for studies related to marketed products.